...
首页> 外文期刊>Molecular Immunology >Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens.
【24h】

Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens.

机译:与乙型肝炎病毒表面抗原结合的新型四价双特异性抗体的产生和表征。

获取原文
获取原文并翻译 | 示例

摘要

Hepatitis B virus (HBV) infection is a worldwide public health problem affecting about 350 million people. HBV envelope contains three surface antigens, called pre-S1, pre-S2 and S. For the prophylaxis of HBV infection, only an anti-S monoclonal antibody was tested for the protective efficacy against HBV infection, but it was shown to be incomplete. In addition, some immune escape mutants carrying mutations on the S antigen were reported. Therefore, a multivalent bispecific antibody rather than a single monoclonal antibody would be more beneficial for the prophylaxis of HBV infection. We have generated a novel tetravalent bispecific antibody with two binding sites for each of the S and pre-S2 antigens. Each of the antigen-binding sites was composed of a single-chain Fv (ScFv). The tetravalent antibody was generated by constructing a single gene encoding a single-chain protein. This protein consisted of an anti-S ScFv whose carboxyl end was tethered, through a 45 amino acid linker, to the amino terminus of anti-preS2 ScFv that in turn was joined to the hinge region of human gamma1 constant region. The single-chain protein was expressed in Chinese hamster ovary cells and secreted in culture supernatant as a homodimeric molecule. The tetravalent bispecific antibody showed both anti-S and anti-pre-S2 binding activities. In addition, the binding affinity of the bispecific antiboy for HBV particles was greater than that of either parental antibody. The tetravalent bispecific antibody is a potentially useful reagent for the prevention and treatment of HBV infection.
机译:乙型肝炎病毒(HBV)感染是一个全球性的公共卫生问题,影响了约3.5亿人。 HBV包膜包含三种表面抗原,分别称为pre-S1,pre-S2和S。为预防HBV感染,仅测试了抗S单克隆抗体对HBV感染的保护功效,但事实证明该抗体不完全。另外,还报道了一些在S抗原上带有突变的免疫逃逸突变体。因此,多价双特异性抗体而不是单一单克隆抗体对于预防HBV感染更有利。我们已经产生了一种新颖的四价双特异性抗体,每个S和pre-S2抗原都有两个结合位点。每个抗原结合位点由单链Fv(ScFv)组成。通过构建编码单链蛋白的单一基因来产生四价抗体。该蛋白由抗S ScFv组成,其羧基末端通过45个氨基酸接头与抗preS2 ScFv的氨基末端束缚在一起,而抗preS2 ScFv的氨基末端又与人gamma1恒定区的铰链区相连。单链蛋白在中国仓鼠卵巢细胞中表达,并在培养上清液中以同型二聚体分子的形式分泌。四价双特异性抗体同时显示出抗S和抗pre S2的结合活性。另外,双特异性抗男孩对HBV颗粒的结合亲和力大于任一亲本抗体的结合亲和力。四价双特异性抗体是用于预防和治疗HBV感染的潜在有用试剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号